##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), genotype, depth and allele frequency for child, mother and father (TRIO).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, NM number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ExAC_hom=Homoyzgous counts for populations ALL, NFE and AFR of ExAC project.
##DESCRIPTION=Kaviar=Allele frequency in Kaviar database.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PP2_HVAR=Polyphen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=PP2_HDIV=Polyphen2 (HDIV) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##FILTER=low_DP=Depth less than 20.
##FILTER=low_MQM=Mean mapping quality of alternate allele less than Q50.
##FILTER=low_QUAL=Variant quality less than Q30.
##FILTER=phylop_high=PhyloP value higher than 1.6 i.e. highly-conserved base and possibly pathognic.
##FILTER=pred_pathogenic=Variant predicted to be pathogenic by one or more prediction tools.
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=anno_pathogenic_clinvar=Variant annotated to be pathogenic by ClinVar.
##FILTER=anno_pathogenic_hgmd=Variant annotated to be pathogenic by HGMD.
##FILTER=anno_high_impact=Variant annotated to have high impact by SnpEff.
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_hom	Kaviar	phyloP	MetaLR	Sift	PP2_HVAR	PP2_HDIV	OMIM	ClinVar	HGMD	COSMIC
chr1	27687466	27687466	G	T	het		QUAL=11756;DP=717;AF=0.51;MQM=60	MAP3K6	missense	MAP3K6:NM_004672.4:missense:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys,MAP3K6:NM_001297609.1:missense:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys		rs35659744	0.1220	0.2230	3300/2798/11	0.2959	0.0290	T,T	T,T,T,T,.	B,B,.	B,B,.				COSM1559293, COSM1559292
chr1	45797505	45797505	C	G	het		QUAL=3729;DP=227;AF=0.50;MQM=60	MUTYH	missense	MUTYH:NM_001128425.1:missense:MODERATE:exon12/16:c.1014G>C:p.Gln338His,MUTYH:NM_001048174.1:missense:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:NM_001293191.1:missense:MODERATE:exon12/16:c.963G>C:p.Gln321His,MUTYH:NM_001293195.1:missense:MODERATE:exon13/17:c.930G>C:p.Gln310His,MUTYH:NM_001048172.1:missense:MODERATE:exon12/16:c.933G>C:p.Gln311His,MUTYH:NM_001048173.1:missense:MODERATE:exon12/16:c.930G>C:p.Gln310His,MUTYH:NM_001293196.1:missense:MODERATE:exon12/16:c.654G>C:p.Gln218His,MUTYH:NM_001048171.1:missense:MODERATE:exon12/16:c.972G>C:p.Gln324His,MUTYH:NM_001293190.1:missense:MODERATE:exon12/16:c.975G>C:p.Gln325His,MUTYH:NM_001293192.1:missense:MODERATE:exon12/16:c.654G>C:p.Gln218His,MUTYH:NM_012222.2:missense:MODERATE:exon12/16:c.1005G>C:p.Gln335His		rs3219489	0.3135	0.2680	4266/1586/319	0.2492	0.0510	T	T,T,T,T,T,T,T,T,T,T,T,T	B,P,B,P,B,B,B	B,B,B,B,B,B,B	604933 [MUTYH (provisional) Adenomas,multiple colorectal|Gastric cancer,somatic|Colorectal adenomatous polyposis,autosomal recessive,with pilomatricomas];	RCV000034684.1 [benign]; RCV000079500.5 [benign]; RCV000131427.2 [benign]; RCV000144634.1 [benign]; 	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH]; 	COSM3751252
chr1	62713224	62713224	C	G	hom		QUAL=1166;DP=37;AF=1.00;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon9/10:c.2803G>C:p.Val935Leu		rs2941679	0.9862	0.9740	57571/31015/5111	0.9598	0.6980	T	T,T,T,T	B,B	B,B				
chr1	62713246	62713246	G	A	het		QUAL=1649;DP=117;AF=0.44;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon9/10:c.2781C>T:p.His927His		rs10889315	0.3189	0.3890	9671/6170/528	0.4209									COSM426544
chr1	62728784	62728784	A	G	hom	phylop_high	QUAL=38030;DP=1190;AF=1.00;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon7/10:c.2519T>C:p.Val840Ala		rs2666472	0.7159	0.7400	33236/17884/1580	0.7338	2.8390	T	T,T,T	B,B	B,B				COSM4144131
chr1	62728838	62728838	T	C	hom	phylop_high	QUAL=35240;DP=1127;AF=1.00;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon7/10:c.2465A>G:p.His822Arg		rs2258470	0.7163	0.7410	33613/18068/1595	0.7340	3.3070	T	T,T,T	B,B	B,B				
chr1	62728861	62728861	T	C	hom		QUAL=35508;DP=1116;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon7/10:c.2442A>G:p.Lys814Lys		rs2260581	0.7163	0.7410	33625/18069/1593	0.7338									
chr1	62728918	62728918	G	A	hom		QUAL=5458;DP=178;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon7/10:c.2385C>T:p.Pro795Pro		rs2262110	0.7161	0.7420	33830/18192/1608	0.7338									
chr1	62732421	62732421	T	C	het	phylop_high	QUAL=13936;DP=859;AF=0.52;MQM=60	KANK4	missense	KANK4:NM_181712.4:missense:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala		rs11207949	0.3055	0.2840	6079/2111/253	0.2449	2.3800	T	T,T,T	B,B	B,B				
chr1	62738904	62738904	T	C	hom		QUAL=1786;DP=60;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.1872A>G:p.Pro624Pro		rs7516290	0.8005	0.7380	30811/15109/3422	0.6733									
chr1	62739198	62739198	G	A	het		QUAL=2166;DP=140;AF=0.49;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.1578C>T:p.Ser526Ser		rs17855078	0.2506	0.3080	6308/3987/186	0.3309									
chr1	62740065	62740065	A	G	het		QUAL=1790;DP=119;AF=0.49;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.711T>C:p.Gly237Gly		rs12127930	0.4822	0.4520	12895/6511/1987	0.4271									COSM4144132
chr1	62740446	62740446	T	C	hom		QUAL=6634;DP=205;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.330A>G:p.Pro110Pro		rs2666506	0.8045	0.7450	33966/15906/3719	0.6742									
chr1	62740449	62740449	T	C	hom		QUAL=6634;DP=205;AF=1.00;MQM=60	KANK4	synonymous	KANK4:NM_181712.4:synonymous:LOW:exon3/10:c.327A>G:p.Ser109Ser		rs2666507	0.7810	0.7370	33241/15890/3051	0.6734									
chr1	78578177	78578177	T	C	het		QUAL=6150;DP=408;AF=0.45;MQM=60	GIPC2	intron	GIPC2:NM_017655.5:intron:MODIFIER:exon3/5:c.608-6900T>C:,GIPC2:NM_001304725.1:intron:MODIFIER:exon3/5:c.386-6900T>C:		rs6666954	0.4489	0.3200	6753/2474/1523	0.2785									
chr1	120458004	120458004	A	T	het	gene_blacklist	QUAL=2121;DP=125;AF=0.56;MQM=60	NOTCH2	synonymous	NOTCH2:NM_024408.3:synonymous:LOW:exon34/34:c.7341T>A:p.Gly2447Gly		rs6685892	0.1925	0.1290	1431/359/637	0.1038						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];			
chr1	120539331	120539331	C	T	het	low_MQM;gene_blacklist	QUAL=30960;DP=1885;AF=0.52;MQM=49	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon4/33:c.751+289G>A:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon4/21:c.751+289G>A:		rs2124109	0.0000	0.4400	0/0/0	0.0000						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];			COSM248829
chr1	120611496	120611496	C	A	het	low_MQM;gene_blacklist	QUAL=393;DP=41;AF=0.49;MQM=47	NOTCH2	intron	NOTCH2:NM_024408.3:intron:MODIFIER:exon1/33:c.73+452G>T:,NOTCH2:NM_001200001.1:intron:MODIFIER:exon1/21:c.73+452G>T:		rs2794164	0.0000	0.0740	12/1/1	0.0000						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];			
chr1	120611960	120611960	C	T	het	low_MQM;gene_blacklist	QUAL=9135;DP=1914;AF=0.21;MQM=46	NOTCH2	missense	NOTCH2:NM_024408.3:missense:MODERATE:exon1/34:c.61G>A:p.Ala21Thr,NOTCH2:NM_001200001.1:missense:MODERATE:exon1/22:c.61G>A:p.Ala21Thr		rs2603926	0.0000	0.2590	0/0/0	0.0000	0.4330	T	T	B,B	B,B	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];			COSM1600651
chr1	120611964	120611964	G	C	het	gene_blacklist	QUAL=21910;DP=1904;AF=0.38;MQM=59	NOTCH2	missense	NOTCH2:NM_024408.3:missense:MODERATE:exon1/34:c.57C>G:p.Cys19Trp,NOTCH2:NM_001200001.1:missense:MODERATE:exon1/22:c.57C>G:p.Cys19Trp		rs11810554	0.0000	0.4060	3/1/2	0.0000	0.7660	T,T	.,T	.,B,B	.,B,B	600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];			COSM132738
chr1	120612003	120612004	GG	-	het	low_MQM;gene_blacklist;anno_high_impact	QUAL=8319;DP=1962;AF=0.20;MQM=47	NOTCH2	frameshift	NOTCH2:NM_024408.3:frameshift:HIGH:exon1/34:c.17_18delCC:p.Pro6fs,NOTCH2:NM_001200001.1:frameshift:HIGH:exon1/22:c.17_18delCC:p.Pro6fs		rs864309621	0.0000	0.3430	0/0/0	0.0000						600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];	RCV000202675.1 [benign]; 		COSM132830
chr1	120612006	120612006	G	A	het	gene_blacklist	QUAL=24079;DP=1986;AF=0.39;MQM=58	NOTCH2	synonymous	NOTCH2:NM_024408.3:synonymous:LOW:exon1/34:c.15C>T:p.Arg5Arg,NOTCH2:NM_001200001.1:synonymous:LOW:exon1/22:c.15C>T:p.Arg5Arg		rs4021006	0.3940	0.4220	259/151/10	0.0000	1.0740					600275 [NOTCH2 (provisional) Alagille syndrome 2|Hajdu-Cheney syndrome];	RCV000173523.1 [uncertain significance]; 		COSM1320072
chr1	120612034	120612034	T	G	het	low_MQM;gene_blacklist	QUAL=7945;DP=1971;AF=0.20;MQM=47	NOTCH2	5'UTR	NOTCH2:NM_024408.3:5'UTR:MODIFIER:exon1/34:c.-14A>C:,NOTCH2:NM_001200001.1:5'UTR:MODIFIER:exon1/22:c.-14A>C:	(CGC)n	rs201668322	0.0000	0.1240	0/0/0	0.0000									
chr2	17942775	17942775	T	A	hom		QUAL=3027;DP=91;AF=1.00;MQM=60	GEN1	missense	GEN1:NM_001130009.1:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr,GEN1:NM_182625.3:missense:MODERATE:exon3/14:c.274T>A:p.Ser92Thr		rs1812152	0.8137	0.7140	31946/12878/3045	0.6259	0.5670	T	T,T,T,T	B	B				
chr2	17954027	17954027	G	A	hom		QUAL=959;DP=29;AF=1.00;MQM=60	GEN1	missense	GEN1:NM_001130009.1:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn,GEN1:NM_182625.3:missense:MODERATE:exon8/14:c.929G>A:p.Ser310Asn		rs300175	0.9770	0.9930	59666/33260/4705	0.9998	-2.1950	T	T,T,T	B	B				
chr2	17962450	17962450	A	G	hom		QUAL=3047;DP=93;AF=1.00;MQM=60	GEN1	synonymous	GEN1:NM_001130009.1:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu,GEN1:NM_182625.3:synonymous:LOW:exon14/14:c.1971A>G:p.Glu657Glu		rs300168	0.5739	0.5760	22044/8822/268	0.5184									
chr2	17962518	17962518	C	T	hom		QUAL=3588;DP=111;AF=1.00;MQM=60	GEN1	missense	GEN1:NM_001130009.1:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile,GEN1:NM_182625.3:missense:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile		rs300169	0.7580	0.6980	30600/12834/1870	0.6245	0.1800	T	T,T,T	B	B				
chr2	47601106	47601106	T	C	het		QUAL=843;DP=41;AF=0.73;MQM=60	EPCAM	missense	EPCAM:NM_002354.2:missense:MODERATE:exon3/9:c.344T>C:p.Met115Thr		rs1126497	0.6661	0.5200	17704/6502/3641	0.4328	0.0400	T	T,T,T	B,B	B,B	185535 [EPCAM (confirmed) Diarrhea 5,with tufting enteropathy,congenital|Colorectal cancer,hereditary nonpolyposis,type 8];	RCV000162369.1 [benign]; 	CM1110060 [CLASS=DP MUT=REF PHEN="Breast cancer increased risk association with" GENE=EPCAM]; 	COSM3927762
chr2	48010488	48010488	G	A	het	low_DP;phylop_high;pred_pathogenic	QUAL=178;DP=14;AF=0.50;MQM=60	MSH6	missense,5'UTR	MSH6:NM_000179.2:missense:MODERATE:exon1/10:c.116G>A:p.Gly39Glu,MSH6:NM_001281492.1:missense:MODERATE:exon1/8:c.116G>A:p.Gly39Glu,MSH6:NM_001281493.1:5'UTR:MODIFIER:exon1/9:c.-621G>A:		rs1042821	0.2009	0.1780	1894/1004/189	0.1724	1.7010	T	T,D,T	B,B,B	B,B,B	600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000030258.3 [benign]; RCV000034489.1 [benign]; RCV000035318.7 [benign]; RCV000132091.2 [benign]; RCV000144626.1 [benign]; 	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6]; 	COSM3749667
chr2	48030692	48030692	T	A	het	low_DP	QUAL=288;DP=17;AF=0.65;MQM=60	MSH6	synonymous	MSH6:NM_000179.2:synonymous:LOW:exon5/10:c.3306T>A:p.Thr1102Thr,MSH6:NM_001281492.1:synonymous:LOW:exon3/8:c.2916T>A:p.Thr972Thr,MSH6:NM_001281493.1:synonymous:LOW:exon4/9:c.2400T>A:p.Thr800Thr,MSH6:NM_001281494.1:synonymous:LOW:exon5/10:c.2400T>A:p.Thr800Thr		rs2020910	0.0493	0.0200	196/0/0	0.0016						600678 [MSH6 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 5|Endometrial cancer,familial|Mismatch repair cancer syndrome];	RCV000030267.3 [benign]; RCV000078313.5 [benign]; RCV000162391.1 [benign]; 		
chr2	147596973	147596973	A	G	het		QUAL=13274;DP=812;AF=0.51;MQM=60	PABPC1P2-ACVR2A	intergenic_region	PABPC1P2-ACVR2A:PABPC1P2-ACVR2A:intergenic_region:MODIFIER::n.147596973A>G:		rs4411641	0.5090	0.4470	11314/4775/1636	0.3998									
chr2	215595164	215595164	G	A	het	phylop_high;pred_pathogenic	QUAL=334;DP=27;AF=0.44;MQM=60	BARD1	missense,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:NM_001282543.1:missense:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys,BARD1:NM_001282545.1:missense:MODERATE:exon6/7:c.619C>T:p.Arg207Cys,BARD1:NM_001282548.1:missense:MODERATE:exon5/6:c.562C>T:p.Arg188Cys,BARD1:NM_001282549.1:missense:MODERATE:exon4/5:c.433C>T:p.Arg145Cys,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon9/10:n.1965C>T:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon8/9:n.1908C>T:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon9/10:n.1164C>T:		rs3738888	0.0054	0.0079	4/2/0	0.0078	5.1650	T	D,D,D,D	P,D	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000130975.4 [benign]; RCV000205691.1 [benign]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109
chr2	215632255	215632255	C	T	het		QUAL=3314;DP=107;AF=0.56;MQM=60	BARD1	missense,intron,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon6/11:c.1519G>A:p.Val507Met,BARD1:NM_001282543.1:missense:MODERATE:exon5/10:c.1462G>A:p.Val488Met,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.216-14976G>A:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-14976G>A:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+24766G>A:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon5/10:n.1512G>A:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon4/9:n.1455G>A:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon5/10:n.711G>A:		rs2070094	0.3662	0.3780	8892/4897/739	0.2758	-5.2640	T	T,T	B,B	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000128872.2 [benign]; 	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1]; 	COSM3757929, COSM3757930
chr2	215632256	215632256	A	G	hom		QUAL=3314;DP=107;AF=0.56;MQM=60	BARD1	synonymous,intron,non_coding_exon	BARD1:NM_000465.3:synonymous:LOW:exon6/11:c.1518T>C:p.His506His,BARD1:NM_001282543.1:synonymous:LOW:exon5/10:c.1461T>C:p.His487His,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.216-14977T>C:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-14977T>C:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+24765T>C:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon5/10:n.1511T>C:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon4/9:n.1454T>C:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon5/10:n.710T>C:		rs2070093	0.7706	0.8130	40550/21983/1885	0.7806						601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000162380.1 [benign]; 		
chr2	215645464	215645464	C	G	het		QUAL=1288;DP=78;AF=0.53;MQM=60	BARD1	missense,intron,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser,BARD1:NM_001282543.1:missense:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser,BARD1:NM_001282545.1:intron:MODIFIER:exon2/6:c.215+16321G>C:,BARD1:NM_001282548.1:intron:MODIFIER:exon1/5:c.159-28185G>C:,BARD1:NM_001282549.1:intron:MODIFIER:exon3/4:c.364+11557G>C:,BARD1:NR_104216.1:intron:MODIFIER:exon3/9:n.507-11428G>C:,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon3/10:n.1127G>C:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon2/9:n.1070G>C:		rs2229571	0.4593	0.5480	19001/12920/845	0.6008	-0.6010	T	T,T	B,B	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000132162.2 [benign]; 	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM3757932, COSM3757931
chr2	215674224	215674224	G	A	het	pred_pathogenic	QUAL=9792;DP=669;AF=0.51;MQM=60	BARD1	missense,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon1/11:c.70C>T:p.Pro24Ser,BARD1:NM_001282543.1:missense:MODERATE:exon1/10:c.70C>T:p.Pro24Ser,BARD1:NM_001282545.1:missense:MODERATE:exon1/7:c.70C>T:p.Pro24Ser,BARD1:NM_001282548.1:missense:MODERATE:exon1/6:c.70C>T:p.Pro24Ser,BARD1:NM_001282549.1:missense:MODERATE:exon1/5:c.70C>T:p.Pro24Ser,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon1/10:n.212C>T:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon1/9:n.212C>T:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon1/10:n.212C>T:		rs1048108	0.3313	0.3670	7357/4010/154	0.3474	0.9680	T	T,D	B	B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000162363.1 [benign]; 	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1]; 	COSM442275, COSM1482743
chr2	220416942	220416942	G	C	hom		QUAL=1037;DP=33;AF=1.00;MQM=60	OBSL1	splice_region&intron	OBSL1:NM_015311.2:splice_region&intron:LOW:exon18/20:c.5309-4C>G:		rs34490902	0.3876	0.4090	7360/4539/456	0.4551						610991 [OBSL1 (confirmed) 3-M syndrome 2];	RCV000175465.1 [benign]; 		
chr2	220417266	220417266	C	T	hom	phylop_high;pred_pathogenic	QUAL=4398;DP=144;AF=1.00;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln		rs59332477	0.3766	0.4160	9523/5689/497	0.4456	3.5850	T	D,T	D	D	610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM3757971
chr2	220419236	220419236	T	C	hom		QUAL=14129;DP=459;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon15/21:c.4836A>G:p.Thr1612Thr		rs10932813	0.9852	0.9960	59432/32960/4475	0.9996						610991 [OBSL1 (confirmed) 3-M syndrome 2];			
chr2	220419339	220419339	T	C	hom		QUAL=21253;DP=676;AF=1.00;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg		rs10932814	0.9611	0.9850	57479/32224/3674	0.9925	0.1950	T	T,T	B	B	610991 [OBSL1 (confirmed) 3-M syndrome 2];			
chr2	220420956	220420956	A	G	hom	pred_pathogenic	QUAL=1234;DP=47;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon14/21:c.4395T>C:p.Asp1465Asp,OBSL1:NM_001173431.1:synonymous:LOW:exon14/14:c.4395T>C:p.Asp1465Asp		rs10932816	0.9637	0.9890	56732/32015/3610	0.9996	-3.7700	T	D,.			610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM4133493
chr2	220421417	220421417	C	G	hom		QUAL=23207;DP=722;AF=1.00;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp,OBSL1:NM_001173431.1:missense:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp		rs1983210	0.7246	0.7400	32983/18089/1813	0.7336	0.9020	T,T	T,T,T,T,.	P,P,B,.	B,P,B,.	610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM442368
chr2	220422686	220422686	C	T	het	pred_pathogenic	QUAL=686;DP=58;AF=0.45;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys,OBSL1:NM_001173431.1:missense:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys		rs72957510	0.0070	0.0055	1/1/0	0.0055	0.5010	T	T,D,T,T	P,B,D,B	P,B,P,B	610991 [OBSL1 (confirmed) 3-M syndrome 2];	RCV000174131.1 [benign]; 		
chr2	220422774	220422774	A	G	hom		QUAL=23733;DP=740;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon11/21:c.3561T>C:p.Pro1187Pro,OBSL1:NM_001173431.1:synonymous:LOW:exon11/14:c.3561T>C:p.Pro1187Pro		rs2278201	0.4191	0.4290	11375/6202/1290	0.4331	-4.6180	T				610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM3757974
chr2	220430203	220430203	C	T	hom		QUAL=23386;DP=734;AF=0.99;MQM=60	OBSL1	missense	OBSL1:NM_015311.2:missense:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys,OBSL1:NM_001173431.1:missense:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys,OBSL1:NM_001173408.1:missense:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys		rs1039898	0.7927	0.8650	45551/27067/1985	0.9043	-0.1200	T	T,T,T,T,T	B,B,B,B	B,B,B,B	610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM4133496, COSM4133495
chr2	220435034	220435034	A	G	hom		QUAL=20039;DP=626;AF=1.00;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon1/21:c.921T>C:p.Leu307Leu,OBSL1:NM_001173431.1:synonymous:LOW:exon1/14:c.921T>C:p.Leu307Leu,OBSL1:NM_001173408.1:synonymous:LOW:exon1/9:c.921T>C:p.Leu307Leu		rs10180675	0.7833	0.8610	44374/26362/1758	0.9044						610991 [OBSL1 (confirmed) 3-M syndrome 2];	RCV000173448.1 [benign]; 		COSM4133504, COSM4133503
chr2	220435375	220435375	G	A	het	low_DP	QUAL=387;DP=18;AF=0.83;MQM=60	OBSL1	synonymous	OBSL1:NM_015311.2:synonymous:LOW:exon1/21:c.580C>T:p.Leu194Leu,OBSL1:NM_001173431.1:synonymous:LOW:exon1/14:c.580C>T:p.Leu194Leu,OBSL1:NM_001173408.1:synonymous:LOW:exon1/9:c.580C>T:p.Leu194Leu		rs1061399	0.3588	0.2610	1102/271/4	0.3695						610991 [OBSL1 (confirmed) 3-M syndrome 2];			COSM4133505, COSM442371
chr3	10085536	10085536	A	G	het	gene_blacklist	QUAL=2996;DP=282;AF=0.44;MQM=60	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon14/43:c.1122A>G:p.Val374Val,FANCD2:NM_001018115.1:synonymous:LOW:exon14/44:c.1122A>G:p.Val374Val		rs34046352	0.0000	0.1220	37/0/37	0.0000						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM3759562, COSM3759563
chr3	10088404	10088404	C	T	het	low_MQM;gene_blacklist	QUAL=516;DP=112;AF=0.21;MQM=17	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon15/43:c.1275C>T:p.Tyr425Tyr,FANCD2:NM_001018115.1:synonymous:LOW:exon15/44:c.1275C>T:p.Tyr425Tyr		rs764447374	0.0000	0.0540	0/0/0	0.0000						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM1417229, COSM1417230
chr3	10088408	10088408	G	-	het	low_MQM;gene_blacklist;anno_high_impact	QUAL=516;DP=112;AF=0.21;MQM=17	FANCD2	splice_donor	FANCD2:NM_033084.3:splice_donor:HIGH:exon15/42:c.1278+1delG:,FANCD2:NM_001018115.1:splice_donor:HIGH:exon15/43:c.1278+1delG:		rs750338758	0.0000	0.0360	0/0/0	0.1616						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM1417231, COSM1417232
chr3	10088410	10088412	AAG	-	het	low_MQM;gene_blacklist	QUAL=516;DP=112;AF=0.21;MQM=17	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon15/42:c.1278+3_1278+5delAAG:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon15/43:c.1278+3_1278+5delAAG:		rs375350046	0.0000	0.0360	0/0/0	0.0000						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			
chr3	10089723	10089723	G	A	het	low_MQM;gene_blacklist	QUAL=704;DP=144;AF=0.21;MQM=39	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon16/43:c.1401G>A:p.Thr467Thr,FANCD2:NM_001018115.1:synonymous:LOW:exon16/44:c.1401G>A:p.Thr467Thr		rs12330369	0.0000	0.4460	0/0/0	0.0000						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			COSM4157098, COSM4157099
chr3	10089738	10089738	A	G	het	low_MQM;gene_blacklist	QUAL=463;DP=115;AF=0.20;MQM=32	FANCD2	splice_region&intron	FANCD2:NM_033084.3:splice_region&intron:LOW:exon16/42:c.1413+3A>G:,FANCD2:NM_001018115.1:splice_region&intron:LOW:exon16/43:c.1413+3A>G:		rs62245508	0.0000	0.4370	0/0/0	0.0000						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			
chr3	10091153	10091153	C	T	het	low_MQM;gene_blacklist	QUAL=126;DP=63;AF=0.17;MQM=40	FANCD2	synonymous	FANCD2:NM_033084.3:synonymous:LOW:exon17/43:c.1509C>T:p.Asn503Asn,FANCD2:NM_001018115.1:synonymous:LOW:exon17/44:c.1509C>T:p.Asn503Asn		rs6785756	0.0000	0.0140	97/35/34	0.0000						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];			
chr3	10106532	10106532	C	T	het	gene_blacklist	QUAL=1466;DP=74;AF=0.64;MQM=60	FANCD2	missense	FANCD2:NM_033084.3:missense:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu,FANCD2:NM_001018115.1:missense:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu		rs3864017	0.0000	0.1550	988/525/211	0.0000	-0.1810	T	T,T,T,T	B,B	B,B	613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];	RCV000120989.1 [not provided]; 		
chr3	10138069	10138069	T	G	het		QUAL=11320;DP=766;AF=0.47;MQM=60	FANCD2,FANCD2OS	synonymous,intron	FANCD2:NM_033084.3:synonymous:LOW:exon42/43:c.4098T>G:p.Leu1366Leu,FANCD2:NM_001018115.1:synonymous:LOW:exon42/44:c.4098T>G:p.Leu1366Leu,FANCD2OS:NM_173472.1:intron:MODIFIER:exon2/2:c.*43+7813A>C:		rs2272125	0.2422	0.1870	2695/850/1177	0.1647						613984 [FANCD2 (provisional) Fanconi anemia,complementation group D2];		CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2]; 	COSM3759565, COSM3759566
chr3	142168331	142168331	C	T	hom		QUAL=1580;DP=48;AF=1.00;MQM=60	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon47/47:c.7875G>A:p.Gln2625Gln		rs1802904	0.9163	0.8650	45665/23944/4913	0.8614						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079601.6 [other]; 		
chr3	142178144	142178144	C	T	het		QUAL=1272;DP=77;AF=0.55;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln		rs2229032	0.1022	0.1320	1212/874/28	0.1578	0.0440	T	T,T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145330.2 [benign]; 		COSM149485
chr3	142188337	142188337	A	C	het	phylop_high;pred_pathogenic	QUAL=11911;DP=679;AF=0.56;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp		rs28910273	0.0020	0.0033	2/1/0	0.0069	2.3460	T	T,D	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145327.1 [uncertain significance]; 		
chr3	142217537	142217537	A	G	het		QUAL=4602;DP=346;AF=0.51;MQM=60	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon32/47:c.5460T>C:p.Tyr1820Tyr		rs2227932	0.0669	0.0930	705/391/2	0.1062						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145320.2 [other]; 		
chr3	142277575	142277575	A	T	het		QUAL=3913;DP=267;AF=0.46;MQM=60	ATR	synonymous	ATR:NM_001184.3:synonymous:LOW:exon8/47:c.1776T>A:p.Gly592Gly		rs2227930	0.5980	0.5530	19239/11031/3356	0.5950						601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145291.5 [other]; 		COSM149486
chr3	142281612	142281612	A	G	het		QUAL=8024;DP=518;AF=0.48;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon4/47:c.632T>C:p.Met211Thr		rs2227928	0.5974	0.5520	19098/10972/3300	0.5955	1.2730	T	T,T	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000079600.6 [other]; 		COSM149487
chr5	57617403	57617403	G	C	het		QUAL=14705;DP=929;AF=0.50;MQM=60	LOC101928569-PLK2	intergenic_region	LOC101928569-PLK2:LOC101928569-PLK2:intergenic_region:MODIFIER::n.57617403G>C:	MLT1E1A	rs37535	0.5719	0.0000	0/0/0	0.0000									
chr5	79950781	79950781	A	G	het		QUAL=526;DP=38;AF=0.47;MQM=60	MSH3,DHFR	missense&splice_region,5'UTR,non_coding_exon	MSH3:NM_002439.4:missense&splice_region:MODERATE:exon1/24:c.235A>G:p.Ile79Val,DHFR:NM_000791.3:5'UTR:MODIFIER:exon1/6:c.-473T>C:,DHFR:NM_001290354.1:5'UTR:MODIFIER:exon1/5:c.-579T>C:,DHFR:NM_001290357.1:5'UTR:MODIFIER:exon1/5:c.-473T>C:,DHFR:NR_110936.1:non_coding_exon:MODIFIER:exon1/4:n.20T>C:		rs1650697	0.7686	0.8540	4978/2224/393	0.0000	-0.4930	T	T,T	B	B	126060 [DHFR (confirmed) Megaloblastic anemia due to dihydrofolate reductase deficiency]:600887 [MSH3 (provisional) Endometrial carcinoma,somatic];		CM003459 [CLASS=DP MUT=REF PHEN="Colon cancer association with" GENE=MSH3]; 	COSM4160035
chr5	80149981	80149981	A	G	hom		QUAL=27935;DP=893;AF=1.00;MQM=60	MSH3	missense	MSH3:NM_002439.4:missense:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg		rs184967	0.9022	0.8730	46317/23581/4199	0.8355	0.4010	T	T,T	B	B	600887 [MSH3 (provisional) Endometrial carcinoma,somatic];		CM076322 [CLASS=DP MUT=REF PHEN="Proximal colon cancer increased risk association with" GENE=MSH3]; 	COSM4160036
chr5	80168937	80168937	G	A	hom		QUAL=3734;DP=111;AF=1.00;MQM=60	MSH3	missense&splice_region	MSH3:NM_002439.4:missense&splice_region:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr		rs26279	0.7202	0.7300	32457/17163/2349	0.7094	1.0140	T	T,T	B	B	600887 [MSH3 (provisional) Endometrial carcinoma,somatic];		CM076321 [CLASS=DP MUT=REF PHEN="Colorectal cancer increased risk association with" GENE=MSH3]; 	
chr5	112162854	112162854	T	C	het		QUAL=2153;DP=181;AF=0.41;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon12/16:c.1458T>C:p.Tyr486Tyr,APC:NM_001127511.2:synonymous:LOW:exon10/14:c.1404T>C:p.Tyr468Tyr,APC:NM_001127510.2:synonymous:LOW:exon13/17:c.1458T>C:p.Tyr486Tyr		rs2229992	0.5100	0.5770	21255/11677/216	0.5902						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035064.7 [benign]; RCV000074147.1 [other]; RCV000131423.2 [benign]; 		COSM1432175
chr5	112164561	112164561	G	A	het		QUAL=3031;DP=177;AF=0.51;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon14/16:c.1635G>A:p.Ala545Ala,APC:NM_001127511.2:synonymous:LOW:exon12/14:c.1581G>A:p.Ala527Ala,APC:NM_001127510.2:synonymous:LOW:exon15/17:c.1635G>A:p.Ala545Ala		rs351771	0.6661	0.6480	25918/12755/1477	0.6169						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035066.7 [benign]; RCV000074153.1 [other]; RCV000162371.1 [benign]; 		COSM3760868
chr5	112175770	112175770	G	A	het		QUAL=6428;DP=417;AF=0.49;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon16/16:c.4479G>A:p.Thr1493Thr,APC:NM_001127511.2:synonymous:LOW:exon14/14:c.4425G>A:p.Thr1475Thr,APC:NM_001127510.2:synonymous:LOW:exon17/17:c.4479G>A:p.Thr1493Thr		rs41115	0.6655	0.6480	25933/12779/1447	0.6167						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035071.7 [benign]; RCV000074234.1 [other]; RCV000162372.1 [benign]; 		COSM3760869
chr5	112176325	112176325	G	A	het		QUAL=303;DP=25;AF=0.52;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon16/16:c.5034G>A:p.Gly1678Gly,APC:NM_001127511.2:synonymous:LOW:exon14/14:c.4980G>A:p.Gly1660Gly,APC:NM_001127510.2:synonymous:LOW:exon17/17:c.5034G>A:p.Gly1678Gly		rs42427	0.6667	0.6500	26051/12877/1489	0.6210						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035074.7 [benign]; RCV000074235.1 [other]; RCV000162373.1 [benign]; 		COSM3760870
chr5	112176559	112176559	T	G	het		QUAL=3990;DP=258;AF=0.49;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon16/16:c.5268T>G:p.Ser1756Ser,APC:NM_001127511.2:synonymous:LOW:exon14/14:c.5214T>G:p.Ser1738Ser,APC:NM_001127510.2:synonymous:LOW:exon17/17:c.5268T>G:p.Ser1756Ser		rs866006	0.6669	0.6500	26034/12847/1478	0.6186						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000166360.1 [likely benign]; RCV000035076.7 [benign]; RCV000074236.1 [other]; RCV000162374.1 [benign]; 		
chr5	112176756	112176756	T	A	het	phylop_high	QUAL=5273;DP=362;AF=0.45;MQM=60	APC	missense	APC:NM_000038.5:missense:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp,APC:NM_001127511.2:missense:MODERATE:exon14/14:c.5411T>A:p.Val1804Asp,APC:NM_001127510.2:missense:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp		rs459552	0.8654	0.7980	38872/19648/4738	0.7650	3.6530	T	T,T,T	B,B	B,B	611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000020089.2 [benign]; RCV000034393.1 [benign]; RCV000035078.8 [benign]; RCV000074239.1 [other]; RCV000132160.2 [benign]; RCV000216852.1 [uncertain significance]; 	CM990164 [CLASS=DP MUT=REF PHEN="Adenomatous polyposis coli association with" GENE=APC]; 	COSM3760871
chr5	112177171	112177171	G	A	het		QUAL=12273;DP=804;AF=0.48;MQM=60	APC	synonymous	APC:NM_000038.5:synonymous:LOW:exon16/16:c.5880G>A:p.Pro1960Pro,APC:NM_001127511.2:synonymous:LOW:exon14/14:c.5826G>A:p.Pro1942Pro,APC:NM_001127510.2:synonymous:LOW:exon17/17:c.5880G>A:p.Pro1960Pro		rs465899	0.6665	0.6480	25923/12754/1497	0.6168						611731 [APC (confirmed) Adenomatous polyposis coli|Gastric cancer,somatic|Adenoma,periampullary,somatic|Hepatoblastoma,somatic|Desmoid disease,hereditary|Colorectal cancer,somatic|Brain tumor-polyposis syndrome 2|Gardner syndrome];	RCV000035080.7 [benign]; RCV000074242.1 [other]; RCV000162375.1 [benign]; 		COSM3760872
chr5	131925483	131925483	G	C	het	phylop_high	QUAL=1006;DP=67;AF=0.49;MQM=60	RAD50	missense	RAD50:NM_005732.3:missense:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala		rs55653181	0.0002	0.0001	0/0/0	0.0000	6.3310	T	T,T,T	P	B	604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder];	RCV000199031.1 [uncertain significance]; 		
chr6	35423662	35423662	A	C	het		QUAL=1125;DP=96;AF=0.40;MQM=60	FANCE	synonymous	FANCE:NM_021922.2:synonymous:LOW:exon2/10:c.387A>C:p.Pro129Pro		rs4713867	0.7780	0.7210	31791/15371/3918	0.6717						613976 [FANCE (provisional) Fanconi anemia,complementation group E];			
chr6	131148863	131148863	A	T	het		QUAL=5426;DP=360;AF=0.52;MQM=60	SMLR1	intron	SMLR1:NM_001195597.1:intron:MODIFIER:exon1/1:c.238+72A>T:		rs9388856	0.4794	0.0000	0/0/0	0.0000									
chr7	6026775	6026775	T	C	hom	gene_blacklist;anno_pathogenic_hgmd	QUAL=524;DP=21;AF=1.00;MQM=59	PMS2	missense,non_coding_exon	PMS2:NM_000535.5:missense:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu,PMS2:NR_003085.2:non_coding_exon:MODIFIER:exon11/15:n.1703A>G:		rs2228006	0.8832	0.8510	44055/24216/4305	0.8457	1.4430	T	T,T,T,T	B,B,B	B,B,B	600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000030365.3 [benign]; RCV000034619.3 [benign]; RCV000121840.3 [benign]; 	BM1497492 [CLASS=DM? MUT=REF PHEN="Colorectal cancer non-polyposis" GENE=PMS2]; 	COSM4162329
chr7	6036980	6036980	G	C	hom	gene_blacklist	QUAL=677;DP=21;AF=1.00;MQM=60	PMS2	synonymous,non_coding_exon	PMS2:NM_000535.5:synonymous:LOW:exon7/15:c.780C>G:p.Ser260Ser,PMS2:NR_003085.2:non_coding_exon:MODIFIER:exon7/15:n.862C>G:		rs1805319	0.8313	0.8090	39906/22309/3695	0.8148						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000162392.1 [benign]; RCV000030372.3 [benign]; RCV000079112.5 [benign]; RCV000131484.2 [benign]; 		COSM4162330
chr7	6037057	6037057	-	A	het	gene_blacklist	QUAL=284;DP=22;AF=0.50;MQM=60	PMS2	splice_region&intron	PMS2:NM_000535.5:splice_region&intron:LOW:exon6/14:c.706-4dupT:,PMS2:NR_003085.2:splice_region&intron:LOW:exon6/14:n.788-4dupT:		rs570998668;rs61373265;rs774538869	0.0264	0.0360	0/0/0	0.0000						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000179768.1 [benign]; RCV000202996.1 [benign]; 		COSM1735804
chr7	128846328	128846328	G	C	hom		QUAL=28484;DP=897;AF=1.00;MQM=60	SMO	synonymous	SMO:NM_005631.4:synonymous:LOW:exon6/12:c.1164G>C:p.Gly388Gly		rs2228617	0.7562	0.7970	38862/23503/2520	0.8391						601500 [SMO (provisional) Basal cell carcinoma,somatic];			COSM4004294
chr7	142460313	142460313	T	C	hom		QUAL=4875;DP=162;AF=0.99;MQM=60	PRSS1	synonymous	PRSS1:NM_002769.4:synonymous:LOW:exon4/5:c.486T>C:p.Asp162Asp		rs6666	0.3966	0.3690	0/0/0	0.0000						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];		CM086253 [CLASS=DP MUT=REF PHEN="Pancreatitis chronic association with" GENE=PRSS1]; 	COSM4161889
chr7	142460865	142460865	T	C	hom		QUAL=10009;DP=345;AF=1.00;MQM=60	PRSS1	synonymous	PRSS1:NM_002769.4:synonymous:LOW:exon5/5:c.738T>C:p.Asn246Asn		rs6667	0.3938	0.5040	16344/11218/985	0.0000						276000 [PRSS1 (confirmed) Pancreatitis,hereditary|Trypsinogen deficiency];			
chr8	90958422	90958422	T	C	het		QUAL=708;DP=46;AF=0.54;MQM=60	NBN	synonymous	NBN:NM_002485.4:synonymous:LOW:exon13/16:c.2016A>G:p.Pro672Pro,NBN:NM_001024688.2:synonymous:LOW:exon14/17:c.1770A>G:p.Pro590Pro		rs1061302	0.3528	0.3450	7411/3552/277	0.3132						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000162357.1 [benign]; 		COSM3763441
chr8	90958530	90958530	T	C	het		QUAL=476;DP=35;AF=0.46;MQM=60	NBN	splice_region&intron	NBN:NM_002485.4:splice_region&intron:LOW:exon12/15:c.1915-7A>G:,NBN:NM_001024688.2:splice_region&intron:LOW:exon13/16:c.1669-7A>G:		rs2308962	0.3790	0.3530	7684/3567/522	0.3144						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];			
chr8	90967711	90967711	A	G	het		QUAL=435;DP=36;AF=0.42;MQM=60	NBN	synonymous	NBN:NM_002485.4:synonymous:LOW:exon10/16:c.1197T>C:p.Asp399Asp,NBN:NM_001024688.2:synonymous:LOW:exon11/17:c.951T>C:p.Asp317Asp		rs709816	0.6086	0.4670	14308/4457/3067	0.3559						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000162376.1 [benign]; RCV000173761.1 [benign]; 		COSM3763442
chr8	90990479	90990479	C	G	het	phylop_high	QUAL=13193;DP=820;AF=0.50;MQM=60	NBN	missense	NBN:NM_002485.4:missense:MODERATE:exon5/16:c.553G>C:p.Glu185Gln,NBN:NM_001024688.2:missense:MODERATE:exon6/17:c.307G>C:p.Glu103Gln		rs1805794	0.3570	0.3450	7417/3546/292	0.3136	2.1330	T	T,T,T,T	B	B	602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000121620.2 [benign]; RCV000162358.1 [benign]; 	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN]; 	COSM3763443
chr8	90995019	90995019	C	T	het	low_DP	QUAL=148;DP=18;AF=0.39;MQM=60	NBN	synonymous,5'UTR	NBN:NM_002485.4:synonymous:LOW:exon2/16:c.102G>A:p.Leu34Leu,NBN:NM_001024688.2:5'UTR:MODIFIER:exon2/17:c.-195G>A:		rs1063045	0.3792	0.3530	7704/3573/531	0.3147						602667 [NBN (confirmed) Nijmegen breakage syndrome|Aplastic anemia|Leukemia,acute lymphoblastic];	RCV000162359.1 [benign]; 		COSM3763444
chr8	107236280	107236280	G	T	hom		QUAL=20513;DP=640;AF=1.00;MQM=60	ZFPM2-AS1-OXR1	intergenic_region	ZFPM2-AS1-OXR1:ZFPM2-AS1-OXR1:intergenic_region:MODIFIER::n.107236280G>T:	LTR33	rs1393978	0.6096	0.0000	0/0/0	0.0000									
chr9	5921881	5921881	G	A	het	phylop_high;pred_pathogenic	QUAL=18215;DP=1039;AF=0.53;MQM=60	KIAA2026	missense	KIAA2026:NM_001017969.2:missense:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile		rs72697396	0.0002	0.0001	0/0/0	0.0001	1.9050	T	D,D	B	B				
chr9	17273878	17273878	A	G	het		QUAL=1290;DP=63;AF=0.71;MQM=60	CNTLN	splice_region&intron	CNTLN:NM_017738.3:splice_region&intron:LOW:exon6/25:c.983+14A>G:,CNTLN:NM_001114395.2:splice_region&intron:LOW:exon6/6:c.983+14A>G:		rs12376938	0.2258	0.2530	4272/2504/149	0.2651									
chr9	17342383	17342383	C	T	hom		QUAL=984;DP=30;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:NM_017738.3:synonymous:LOW:exon12/26:c.1827C>T:p.Asp609Asp		rs1442527	0.9495	0.9860	58803/33327/3518	0.9994									
chr9	17394536	17394536	C	T	hom		QUAL=1755;DP=55;AF=1.00;MQM=60	CNTLN	missense	CNTLN:NM_017738.3:missense:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile		rs7035276	0.7806	0.8220	39183/24109/2187	0.8763	0.3250	T	T,T,T	B,B,B	B,B,B				
chr9	17394996	17394996	T	C	hom		QUAL=3134;DP=97;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:NM_017738.3:synonymous:LOW:exon15/26:c.2544T>C:p.His848His		rs3739489	0.8411	0.8790	46938/28083/2939	0.9149									
chr9	17409366	17409366	G	A	hom		QUAL=12093;DP=378;AF=1.00;MQM=60	CNTLN	synonymous	CNTLN:NM_017738.3:synonymous:LOW:exon16/26:c.2691G>A:p.Thr897Thr		rs2780211	0.8389	0.8750	46375/27819/2946	0.9115									COSM3982792
chr9	17457513	17457513	A	-	hom	low_DP;anno_high_impact	QUAL=104;DP=4;AF=1.00;MQM=60	CNTLN	splice_acceptor	CNTLN:NM_017738.3:splice_acceptor:HIGH:exon18/25:c.3115-2delA:	(TATATT)n	rs35399020;rs397766990	0.7342	0.8360	40782/25898/1543	0.9938									
chr9	21971137	21971137	T	G	het	phylop_high;pred_pathogenic	QUAL=334;DP=24;AF=0.88;MQM=60	CDKN2A	missense,synonymous,3'UTR	CDKN2A:NM_001195132.1:missense:MODERATE:exon2/4:c.221A>C:p.Asp74Ala,CDKN2A:NM_000077.4:missense:MODERATE:exon2/3:c.221A>C:p.Asp74Ala,CDKN2A:NM_058195.3:synonymous:LOW:exon2/3:c.264A>C:p.Arg88Arg,CDKN2A:NM_058197.4:3'UTR:MODIFIER:exon2/3:c.*144A>C:		rs200429615	0.0000	0.0011	0/0/0	0.0000	5.3730	D	D,D	D	D	156540 [MTAP (confirmed) Diaphyseal medullary stenosis with malignant fibrous histiocytoma]:600160 [CDKN2A (confirmed) Melanoma,cutaneous malignant,2|Melanoma and neural system tumor syndrome|Pancreatic cancer/melanoma syndrome|Orolaryngeal cancer,multiple,];			COSM4163711, COSM4163712, COSM4163709, COSM4163710
chr9	35074917	35074917	T	C	hom		QUAL=3086;DP=96;AF=1.00;MQM=60	FANCG	splice_region&intron	FANCG:NM_004629.1:splice_region&intron:LOW:exon12/13:c.1636+7A>G:		rs587118	0.2202	0.3960	11389/8269/33	0.4993						602956 [FANCG (confirmed) Fanconi anemia,complementation group G];			
chr9	90062823	90062823	A	G	hom		QUAL=14796;DP=513;AF=1.00;MQM=60	C9orf170-DAPK1	intergenic_region	C9orf170-DAPK1:C9orf170-DAPK1:intergenic_region:MODIFIER::n.90062823A>G:		rs12682834	0.6368	0.6430	23839/12412/915	0.6168									
chr9	98209594	98209594	G	A	het	phylop_high;pred_pathogenic	QUAL=1290;DP=64;AF=0.67;MQM=60	PTCH1	missense	PTCH1:NM_000264.3:missense:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu,PTCH1:NM_001083607.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083606.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083604.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083605.1:missense:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu,PTCH1:NM_001083602.1:missense:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu,PTCH1:NM_001083603.1:missense:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu		rs357564	0.3968	0.3800	9126/3704/255	0.3298	9.4050	T	D,D,D,D,D,D,D,D	P,P,P	P,P,B	601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];	RCV000034575.1 [benign]; RCV000078463.5 [benign]; 	CM056376 [CLASS=DP MUT=REF PHEN="Skin cancer association with" GENE=PTCH1]; 	COSM1638395, COSM1638394, COSM1638396, COSM1638397
chr9	98232224	98232224	A	-	het		QUAL=705;DP=56;AF=0.54;MQM=60	PTCH1,LOC100507346	splice_region&intron,non_coding_exon	PTCH1:NM_000264.3:splice_region&intron:LOW:exon12/23:c.1729-11delT:,PTCH1:NM_001083607.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083606.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083604.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083605.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083602.1:splice_region&intron:LOW:exon12/23:c.1531-11delT:,PTCH1:NM_001083603.1:splice_region&intron:LOW:exon12/23:c.1726-11delT:,LOC100507346:NR_038982.1:non_coding_exon:MODIFIER:exon4/4:n.1887delA:		rs779000277	0.0000	0.0014	2/2/0	0.0018						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];			
chr10	43595968	43595968	A	G	hom		QUAL=16021;DP=513;AF=1.00;MQM=60	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon2/20:c.135A>G:p.Ala45Ala,RET:NM_020630.4:synonymous:LOW:exon2/19:c.135A>G:p.Ala45Ala		rs1800858	0.7536	0.7360	33200/17899/4676	0.7394						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000014967.2 [other]; RCV000127776.1 [benign]; RCV000205827.1 [benign]; RCV000216697.1 [not provided]; RCV000153833.3 [benign]; 	CM020759 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 	COSM4144677, COSM4144678
chr10	43613843	43613843	G	T	hom		QUAL=37353;DP=1130;AF=1.00;MQM=60	RET	synonymous	RET:NM_020975.4:synonymous:LOW:exon13/20:c.2307G>T:p.Leu769Leu,RET:NM_020630.4:synonymous:LOW:exon13/19:c.2307G>T:p.Leu769Leu		rs1800861	0.7125	0.7420	33769/19608/4074	0.7653						164761 [RET (confirmed) Multiple endocrine neoplasia IIA|Medullary thyroid carcinoma|Multiple endocrine neoplasia IIB|Central hypoventilation syndrome,congenital|Pheochromocytoma|Renal agenesis|Hirschsprung disease,susceptibility to,1];	RCV000021844.1 [benign]; RCV000127779.1 [benign]; RCV000154625.1 [benign]; RCV000203706.1 [benign]; RCV000153835.3 [benign]; 	CM014825 [CLASS=DP MUT=REF PHEN="Hirschsprung disease association with" GENE=RET]; 	
chr10	88635779	88635779	C	A	het	phylop_high	QUAL=1068;DP=69;AF=0.57;MQM=51	BMPR1A	missense	BMPR1A:NM_004329.2:missense:MODERATE:exon3/13:c.4C>A:p.Pro2Thr		rs11528010	0.4998	0.3560	9160/2415/2340	0.2562	3.7680	T	T,T	B	B	601299 [BMPR1A (confirmed) Polyposis,juvenile intestinal|Polyposis syndrome,hereditary mixed,2|Juvenile polyposis syndrome,infantile form];	RCV000034703.1 [benign]; RCV000120253.1 [not provided]; RCV000131909.2 [benign]; 		COSM3752019, COSM3752020
chr10	104264107	104264107	C	T	hom		QUAL=9768;DP=383;AF=1.00;MQM=60	SUFU	splice_region&intron	SUFU:NM_016169.3:splice_region&intron:LOW:exon1/11:c.182+16C>T:,SUFU:NM_001178133.1:splice_region&intron:LOW:exon1/10:c.182+16C>T:		rs2274351	0.3962	0.4770	14438/9985/516	0.5600						607035 [SUFU (confirmed) Medulloblastoma,desmoplastic|Meningioma,familial,susceptibility to|Basal cell nevus syndrome];			
chr10	104387019	104387019	T	C	het		QUAL=18073;DP=1146;AF=0.49;MQM=60	SUFU	splice_region&intron	SUFU:NM_016169.3:splice_region&intron:LOW:exon11/11:c.1365+19T>C:		rs12414407	0.7196	0.6630	26892/13897/2970	0.6521						607035 [SUFU (confirmed) Medulloblastoma,desmoplastic|Meningioma,familial,susceptibility to|Basal cell nevus syndrome];			
chr10	104389932	104389932	T	G	hom		QUAL=58910;DP=1835;AF=1.00;MQM=60	SUFU	3'UTR	SUFU:NM_016169.3:3'UTR:MODIFIER:exon12/12:c.*20T>G:		rs4917980	0.9974	0.9990	60625/33359/5139	1.0000									
chr11	13102924	13102924	G	A	het		QUAL=355;DP=25;AF=0.52;MQM=60	RASSF10-ARNTL	intergenic_region	RASSF10-ARNTL:RASSF10-ARNTL:intergenic_region:MODIFIER::n.13102924G>A:		rs2583136	0.5052	0.0000	0/0/0	0.0000									
chr11	64572018	64572018	T	C	hom		QUAL=8010;DP=244;AF=1.00;MQM=60	MEN1	missense	MEN1:NM_000244.3:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130800.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130801.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130799.2:missense:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala,MEN1:NM_130802.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130803.2:missense:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala,MEN1:NM_130804.2:missense:MODERATE:exon11/11:c.1636A>G:p.Thr546Ala		rs2959656	0.8345	0.9380	54048/33008/2619	0.9959	0.1310	T	T,T,T,T,T,T,T,T,T,T	B,B,B	B,B,B	613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	RCV000034785.3 [benign]; RCV000082334.5 [benign]; RCV000204881.1 [benign]; RCV000210359.1 [uncertain significance]; RCV000121334.3 [benign]; 	CM085535 [CLASS=DFP MUT=REF PHEN="Impaired sensitisation to apoptosis" GENE=MEN1]; 	COSM255213
chr11	64572557	64572557	A	G	hom		QUAL=6434;DP=197;AF=1.00;MQM=60	MEN1	synonymous	MEN1:NM_000244.3:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130800.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130801.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130799.2:synonymous:LOW:exon9/10:c.1299T>C:p.His433His,MEN1:NM_130802.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130803.2:synonymous:LOW:exon9/10:c.1314T>C:p.His438His,MEN1:NM_130804.2:synonymous:LOW:exon10/11:c.1314T>C:p.His438His		rs540012	0.9760	0.9930	59759/33299/4389	0.9997						613733 [MEN1 (confirmed) Multiple endocrine neoplasia 1|Carcinoid tumor of lung|Parathyroid adenoma,somatic|Lipoma,somatic|Angiofibroma,somatic|Adrenal adenoma,somatic];	RCV000205798.1 [benign]; RCV000153486.2 [benign]; 		
chr11	108175394	108175394	T	C	het	low_DP	QUAL=195;DP=14;AF=0.57;MQM=60	ATM	splice_region&intron	ATM:NM_000051.3:splice_region&intron:LOW:exon36/62:c.5497-8T>C:		rs3092829	0.0132	0.0220	38/34/0	0.0334						607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000119146.2 [benign]; RCV000128919.2 [benign]; 		
chr11	108175462	108175462	G	A	het	phylop_high	QUAL=470;DP=30;AF=0.53;MQM=60	ATM	missense	ATM:NM_000051.3:missense:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn		rs1801516	0.0669	0.1100	953/666/5	0.1402	6.3420	T	T,T	B	B	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000116427.4 [other]; RCV000131720.2 [benign]; 	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM]; 	COSM41596, COSM3736031
chr11	108183167	108183167	A	G	hom		QUAL=14137;DP=442;AF=1.00;MQM=60	ATM	missense	ATM:NM_000051.3:missense:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser		rs659243	1.0000	1.0000	60654/33353/5170	0.0000	-1.0580	T	T,T	B,B	B,B	607585 [ATM (confirmed) Ataxia-telangiectasia|Lymphoma,B-cell non-Hodgkin,somatic|Breast cancer,susceptibility to|Lymphoma,mantle cell|T-cell prolymphocytic leukemia,somatic];	RCV000128947.1 [benign]; RCV000120149.2 [benign]; 		
chr11	125525195	125525195	A	G	hom		QUAL=1947;DP=58;AF=1.00;MQM=60	CHEK1	missense,non_coding_exon	CHEK1:NM_001114121.2:missense:MODERATE:exon13/14:c.1411A>G:p.Ile471Val,CHEK1:NM_001114122.2:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:NM_001244846.1:missense:MODERATE:exon12/12:c.1309A>G:p.Ile437Val,CHEK1:NM_001274.5:missense:MODERATE:exon13/13:c.1411A>G:p.Ile471Val,CHEK1:NR_045204.1:non_coding_exon:MODIFIER:exon12/12:n.2084A>G:,CHEK1:NR_045205.1:non_coding_exon:MODIFIER:exon13/13:n.1845A>G:		rs506504	0.9858	0.9730	57363/30871/5146	0.9637	1.1780	T	T,T,T,T,T,T,T	B,B,B	B,B,B				
chr13	32911888	32911888	A	G	het		QUAL=1006;DP=71;AF=0.48;MQM=60	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.3396A>G:p.Lys1132Lys		rs1801406	0.2668	0.2930	5391/3115/273	0.3074						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113169.1 [benign]; RCV000113170.4 [benign]; RCV000114982.2 [benign]; RCV000130987.2 [benign]; RCV000152873.3 [benign]; 		
chr13	32913055	32913055	A	G	hom		QUAL=31705;DP=969;AF=1.00;MQM=60	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.4563A>G:p.Leu1521Leu		rs206075	0.9740	0.9930	59672/33182/4417	0.9994						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113321.1 [benign]; RCV000160224.1 [benign]; RCV000164515.1 [likely benign]; RCV000198429.1 [likely benign]; RCV000119245.2 [benign]; RCV000132170.2 [benign]; RCV000152875.5 [benign]; 		
chr13	32915005	32915005	G	C	hom		QUAL=857;DP=26;AF=1.00;MQM=60	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon11/27:c.6513G>C:p.Val2171Val		rs206076	0.9736	0.9930	59677/33272/4398	0.9994						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113602.1 [not provided]; RCV000119246.2 [benign]; RCV000152878.5 [benign]; RCV000162377.1 [benign]; RCV000163332.1 [likely benign]; RCV000168590.2 [other]; RCV000173959.1 [uncertain significance]; RCV000195987.2 [likely benign]; 		COSM4147690, COSM4147689
chr13	32929232	32929232	A	G	het		QUAL=541;DP=35;AF=0.54;MQM=60	BRCA2	synonymous	BRCA2:NM_000059.3:synonymous:LOW:exon14/27:c.7242A>G:p.Ser2414Ser		rs1799955	0.2326	0.2240	3228/1556/231	0.2133						600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000113739.4 [benign]; RCV000123992.2 [benign]; RCV000130994.2 [benign]; RCV000152882.3 [benign]; 		
chr13	32929387	32929387	T	C	hom	phylop_high;anno_pathogenic_hgmd	QUAL=19134;DP=580;AF=1.00;MQM=60	BRCA2	missense	BRCA2:NM_000059.3:missense:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala		rs169547	0.9758	0.9940	59912/33304/4522	0.9994	2.3530	T	T,T			600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2|Fanconi anemia,complementation group D1|Prostate cancer|Breast cancer,male,susceptibility to|Wilms tumor|Medulloblastoma|Glioblastoma 3|Pre-B-cell acute lymphoblastic leukemia|Pancreatic cancer];	RCV000045197.4 [benign]; RCV000113751.2 [benign]; RCV000168597.1 [benign]; RCV000203672.1 [benign]; RCV000120357.5 [benign]; RCV000207137.1 [uncertain significance]; 	CM960194 [CLASS=DM? MUT=REF PHEN="Breast cancer" GENE=BRCA2]; 	
chr13	79766188	79766188	A	G	het		QUAL=13317;DP=813;AF=0.52;MQM=60	LINC00331-RBM26	intergenic_region	LINC00331-RBM26:LINC00331-RBM26:intergenic_region:MODIFIER::n.79766188A>G:		rs2988039	0.5066	0.3470	7871/1863/1908	0.2553									
chr14	45606387	45606387	A	G	het	pred_pathogenic	QUAL=743;DP=52;AF=0.48;MQM=60	FANCM	missense	FANCM:NM_020937.3:missense:MODERATE:exon2/23:c.624A>G:p.Ile208Met,FANCM:NM_001308134.1:missense:MODERATE:exon2/11:c.624A>G:p.Ile208Met,FANCM:NM_001308133.1:missense:MODERATE:exon2/22:c.624A>G:p.Ile208Met		rs45547534	0.0054	0.0110	9/6/0	0.0151	0.1250	T	D,D,D	D,D,P	D,D,P				COSM3753963
chr14	104165753	104165753	G	A	het		QUAL=15605;DP=945;AF=0.51;MQM=60	XRCC3,KLC1	missense,intron	XRCC3:NM_001100118.1:missense:MODERATE:exon7/9:c.722C>T:p.Thr241Met,XRCC3:NM_001100119.1:missense:MODERATE:exon8/10:c.722C>T:p.Thr241Met,XRCC3:NM_005432.3:missense:MODERATE:exon8/10:c.722C>T:p.Thr241Met,KLC1:NM_001130107.1:intron:MODIFIER:exon14/15:c.1782-1239G>A:,KLC1:NM_182923.3:intron:MODIFIER:exon13/14:c.1651-1239G>A:		rs861539	0.2169	0.2920	5751/4513/219	0.3782	0.6420	T	T,T,T,T,T,T	P	B	600675 [XRCC3 (provisional) Melanoma,cutaneous malignant,6|Breast cancer,susceptibility to];	RCV000009500.2 [other]; 	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3]; 	COSM1128325
chr15	43701947	43701947	A	-	het		QUAL=708;DP=58;AF=0.43;MQM=60	TP53BP1	splice_region&intron	TP53BP1:NM_001141980.1:splice_region&intron:LOW:exon24/27:c.5306-8delT:,TP53BP1:NM_001141979.1:splice_region&intron:LOW:exon24/27:c.5300-8delT:,TP53BP1:NM_005657.2:splice_region&intron:LOW:exon24/27:c.5291-8delT:		rs397711844;rs56813954	0.2502	0.2540	2441/1310/43	0.0000									COSM1608394
chr15	43707808	43707808	A	T	het		QUAL=1981;DP=128;AF=0.48;MQM=60	TP53BP1	synonymous	TP53BP1:NM_001141980.1:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_001141979.1:synonymous:LOW:exon23/28:c.5073T>A:p.Ser1691Ser,TP53BP1:NM_005657.2:synonymous:LOW:exon23/28:c.5058T>A:p.Ser1686Ser		rs2230451	0.1286	0.1630	1830/1156/143	0.1900									COSM3754329
chr15	43724646	43724646	T	G	hom	phylop_high	QUAL=19904;DP=621;AF=1.00;MQM=60	TP53BP1	missense	TP53BP1:NM_001141980.1:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_001141979.1:missense:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln,TP53BP1:NM_005657.2:missense:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln		rs2602141	0.5264	0.3750	10244/3163/3807	0.3036	3.2610	T	T,T,T,T	B,B,B,B	B,B,B,B			CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3754330
chr15	43748304	43748304	A	G	hom		QUAL=29997;DP=943;AF=1.00;MQM=60	TP53BP1	synonymous	TP53BP1:NM_001141980.1:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_001141979.1:synonymous:LOW:exon12/28:c.2502T>C:p.Asp834Asp,TP53BP1:NM_005657.2:synonymous:LOW:exon12/28:c.2487T>C:p.Asp829Asp		rs690367	0.5262	0.3740	10243/3157/3934	0.3032									COSM3754331
chr15	43762196	43762196	C	T	het	pred_pathogenic	QUAL=3861;DP=201;AF=0.59;MQM=60	TP53BP1	missense	TP53BP1:NM_001141980.1:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_001141979.1:missense:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser,TP53BP1:NM_005657.2:missense:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser		rs689647	0.3824	0.2060	4213/530/2154	0.1130	1.1390	T	D,D,D,D,T	B,B,B,B	B,B,B,B			CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1]; 	COSM3754332
chr15	43767774	43767774	G	C	hom		QUAL=3586;DP=115;AF=1.00;MQM=60	TP53BP1	missense	TP53BP1:NM_001141980.1:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_001141979.1:missense:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu,TP53BP1:NM_005657.2:missense:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu		rs560191	0.5258	0.3740	10224/3146/3930	0.3029	0.2260	T	T,T,T,T,T	B,B,B,B	B,B,B,B			CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1]; 	COSM3744615
chr16	3639139	3639139	A	G	het		QUAL=1619;DP=99;AF=0.53;MQM=60	SLX4	synonymous	SLX4:NM_032444.2:synonymous:LOW:exon12/15:c.4500T>C:p.Asn1500Asn		rs3810812	0.7396	0.6110	23691/8817/3963	0.5077						613278 [SLX4 (provisional) Fanconi anemia,complementation group P];			
chr16	3639230	3639230	G	A	het	anno_pathogenic_hgmd	QUAL=1724;DP=108;AF=0.49;MQM=60	SLX4	missense	SLX4:NM_032444.2:missense:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0/0/0	0.0002	0.3390	T	T	P	B	613278 [SLX4 (provisional) Fanconi anemia,complementation group P];		CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 	
chr16	68771372	68771372	C	T	hom		QUAL=3882;DP=120;AF=1.00;MQM=60	CDH1	splice_region&intron	CDH1:NM_004360.4:splice_region&intron:LOW:exon1/15:c.48+6C>T:,CDH1:NM_001317184.1:splice_region&intron:LOW:exon1/14:c.48+6C>T:,CDH1:NM_001317185.1:splice_region&intron:LOW:exon1/15:c.-1568+6C>T:,CDH1:NM_001317186.1:splice_region&intron:LOW:exon1/14:c.-1772+6C>T:		rs3743674	0.7634	0.7310	5304/2436/102	0.9074						192090 [CDH1 (confirmed) Endometrial carcinoma,somatic|Ovarian carcinoma,somatic|Breast cancer,lobular|Gastric cancer,familial diffuse,with or without cleft lip and/or palate|Prostate cancer,susceptibility to];	RCV000132163.3 [benign]; RCV000173339.1 [benign]; 		
chr16	68857441	68857441	T	C	het		QUAL=18115;DP=1126;AF=0.52;MQM=60	CDH1	synonymous	CDH1:NM_004360.4:synonymous:LOW:exon13/16:c.2076T>C:p.Ala692Ala,CDH1:NM_001317184.1:synonymous:LOW:exon12/15:c.1893T>C:p.Ala631Ala,CDH1:NM_001317185.1:synonymous:LOW:exon13/16:c.528T>C:p.Ala176Ala,CDH1:NM_001317186.1:synonymous:LOW:exon12/15:c.111T>C:p.Ala37Ala		rs1801552	0.7187	0.6550	26404/13014/4084	0.6322						192090 [CDH1 (confirmed) Endometrial carcinoma,somatic|Ovarian carcinoma,somatic|Breast cancer,lobular|Gastric cancer,familial diffuse,with or without cleft lip and/or palate|Prostate cancer,susceptibility to];	RCV000132164.2 [benign]; 	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1]; 	COSM3755010
chr16	81816733	81816733	C	T	het		QUAL=6224;DP=419;AF=0.50;MQM=60	PLCG2	intron	PLCG2:NM_002661.4:intron:MODIFIER:exon1/32:c.-47-2815C>T:		rs8045964	0.4241	0.3990	6242/2864/337	0.4231									
chr16	89836323	89836323	C	T	het		QUAL=1084;DP=92;AF=0.40;MQM=60	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp,FANCA:NM_001286167.1:missense:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp		rs7195066	0.6667	0.4670	16070/3144/2387	0.3142	0.3050	T	T	B,B	B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120927.1 [not provided]; 	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA]; 	COSM435949
chr16	89838078	89838078	A	G	het		QUAL=15822;DP=1029;AF=0.48;MQM=60	FANCA	splice_region&intron	FANCA:NM_000135.2:splice_region&intron:LOW:exon23/42:c.2151+8T>C:,FANCA:NM_001286167.1:splice_region&intron:LOW:exon23/42:c.2151+8T>C:		rs1800340	0.5599	0.4310	12977/3039/1411	0.3077						607139 [FANCA (confirmed) Fanconi anemia,complementation group A];			
chr16	89849480	89849480	C	T	hom		QUAL=6662;DP=197;AF=1.00;MQM=60	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser,FANCA:NM_001286167.1:missense:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser		rs2239359	0.6240	0.4990	16447/5298/2452	0.3810	-0.0380	T	T	B,B	B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120917.1 [not provided]; 	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 	
chr16	89866043	89866043	T	C	het		QUAL=11426;DP=715;AF=0.50;MQM=60	FANCA	missense	FANCA:NM_000135.2:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001286167.1:missense:MODERATE:exon9/43:c.796A>G:p.Thr266Ala,FANCA:NM_001018112.1:missense:MODERATE:exon9/11:c.796A>G:p.Thr266Ala		rs7190823	0.6905	0.5170	18422/4824/2761	0.3937	0.4020	T	T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	607139 [FANCA (confirmed) Fanconi anemia,complementation group A];	RCV000120967.1 [not provided]; 	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA]; 	
chr17	7574001	7574001	T	A	het		QUAL=107;DP=23;AF=0.26;MQM=60	TP53	synonymous,3'UTR	TP53:NM_000546.5:synonymous:LOW:exon10/11:c.1026A>T:p.Arg342Arg,TP53:NM_001126115.1:synonymous:LOW:exon6/7:c.630A>T:p.Arg210Arg,TP53:NM_001276697.1:synonymous:LOW:exon6/7:c.549A>T:p.Arg183Arg,TP53:NM_001126112.2:synonymous:LOW:exon10/11:c.1026A>T:p.Arg342Arg,TP53:NM_001126118.1:synonymous:LOW:exon9/10:c.909A>T:p.Arg303Arg,TP53:NM_001276760.1:synonymous:LOW:exon10/11:c.909A>T:p.Arg303Arg,TP53:NM_001276761.1:synonymous:LOW:exon10/11:c.909A>T:p.Arg303Arg,TP53:NM_001126116.1:3'UTR:MODIFIER:exon7/8:c.*133A>T:,TP53:NM_001126117.1:3'UTR:MODIFIER:exon7/8:c.*45A>T:,TP53:NM_001276698.1:3'UTR:MODIFIER:exon7/8:c.*133A>T:,TP53:NM_001276699.1:3'UTR:MODIFIER:exon7/8:c.*45A>T:,TP53:NM_001126113.2:3'UTR:MODIFIER:exon11/12:c.*45A>T:,TP53:NM_001126114.2:3'UTR:MODIFIER:exon11/12:c.*133A>T:,TP53:NM_001276695.1:3'UTR:MODIFIER:exon11/12:c.*45A>T:,TP53:NM_001276696.1:3'UTR:MODIFIER:exon11/12:c.*133A>T:			0.0000	0.0000	0/0/0	0.0000						191170 [TP53 (confirmed) Colorectal cancer|Li-Fraumeni syndrome|Hepatocellular carcinoma|Osteosarcoma|Choroid plexus papilloma|Nasopharyngeal carcinoma|Pancreatic cancer|Adrenal cortical carcinoma|Breast cancer|Basal cell carcinoma 7|Glioma susceptibility 1];			
chr17	7579472	7579472	G	C	het		QUAL=9223;DP=552;AF=0.54;MQM=60	TP53	missense	TP53:NM_000546.5:missense:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:NM_001126112.2:missense:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:NM_001126113.2:missense:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:NM_001126114.2:missense:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:NM_001126118.1:missense:MODERATE:exon3/10:c.98C>G:p.Pro33Arg,TP53:NM_001276695.1:missense:MODERATE:exon4/12:c.98C>G:p.Pro33Arg,TP53:NM_001276696.1:missense:MODERATE:exon4/12:c.98C>G:p.Pro33Arg,TP53:NM_001276760.1:missense:MODERATE:exon4/11:c.98C>G:p.Pro33Arg,TP53:NM_001276761.1:missense:MODERATE:exon4/11:c.98C>G:p.Pro33Arg		rs1042522	0.5429	0.6590	27306/18000/773	0.7452	1.0150	T	T,T,T,T,T,T,T,T,T	B,B,B,B,P	B,B,B,B,B	191170 [TP53 (confirmed) Colorectal cancer|Li-Fraumeni syndrome|Hepatocellular carcinoma|Osteosarcoma|Choroid plexus papilloma|Nasopharyngeal carcinoma|Pancreatic cancer|Adrenal cortical carcinoma|Breast cancer|Basal cell carcinoma 7|Glioma susceptibility 1];	RCV000152112.1 [benign]; RCV000013144.2 [benign]; RCV000034639.1 [benign]; RCV000079202.5 [benign]; RCV000132165.2 [benign]; RCV000144668.1 [uncertain significance]; RCV000211157.1 [drug response]; RCV000211212.1 [drug response]; RCV000211311.1 [drug response]; RCV000211338.1 [drug response]; RCV000211395.1 [drug response]; RCV000164487.1 [uncertain significance]; 	CM961374 [CLASS=DFP MUT=REF PHEN="Lung cancer association with" GENE=TP53]; 	COSM250061, COSM3766192, COSM3766191, COSM3766190, COSM3766193
chr17	29553485	29553485	G	A	hom		QUAL=2516;DP=83;AF=1.00;MQM=60	NF1	synonymous	NF1:NM_001042492.2:synonymous:LOW:exon18/58:c.2034G>A:p.Pro678Pro,NF1:NM_000267.3:synonymous:LOW:exon18/57:c.2034G>A:p.Pro678Pro		rs2285892	0.4968	0.3820	9925/3078/2462	0.2891						613113 [NF1 (confirmed) Neurofibromatosis,type 1|Leukemia,juvenile myelomonocytic|Neurofibromatosis,familial spinal|Neurofibromatosis-Noonan syndrome|Watson syndrome];	RCV000162648.1 [benign]; RCV000219876.1 [benign]; 		
chr17	33433487	33433487	C	T	hom		QUAL=2504;DP=83;AF=1.00;MQM=60	RAD51D,RAD51L3-RFFL	missense,non_coding_exon	RAD51D:NM_001142571.1:missense:MODERATE:exon6/10:c.554G>A:p.Arg185Gln,RAD51D:NM_002878.3:missense:MODERATE:exon6/10:c.494G>A:p.Arg165Gln,RAD51D:NM_133629.2:missense:MODERATE:exon3/7:c.158G>A:p.Arg53Gln,RAD51L3-RFFL:NR_037714.1:non_coding_exon:MODIFIER:exon2/7:n.246G>A:,RAD51D:NR_037711.1:non_coding_exon:MODIFIER:exon5/9:n.631G>A:,RAD51D:NR_037712.1:non_coding_exon:MODIFIER:exon4/8:n.496G>A:		rs4796033	0.0950	0.1480	1568/680/7	0.1427	1.3260	T	T,T,T,T,T,T,T	B,B,B,B	B,B,B,B	602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4];	RCV000131069.2 [benign]; 		
chr17	33445549	33445549	G	A	het		QUAL=1707;DP=104;AF=0.51;MQM=60	RAD51D,RAD51L3-RFFL	synonymous,intron	RAD51D:NM_002878.3:synonymous:LOW:exon3/10:c.234C>T:p.Ser78Ser,RAD51L3-RFFL:NR_037714.1:intron:MODIFIER:exon1/6:n.232+2761C>T:,RAD51D:NM_001142571.1:intron:MODIFIER:exon2/9:c.144+581C>T:,RAD51D:NM_133629.2:intron:MODIFIER:exon2/6:c.144+581C>T:,RAD51D:NR_037711.1:intron:MODIFIER:exon2/8:n.400+581C>T:,RAD51D:NR_037712.1:intron:MODIFIER:exon2/7:n.400+581C>T:		rs9901455	0.1875	0.1180	1176/263/469	0.0820						602954 [RAD51D (provisional) Breast-ovarian cancer,familial,susceptibility to,4];	RCV000162563.1 [benign]; 		
chr17	41223094	41223094	T	C	het	pred_pathogenic	QUAL=5538;DP=414;AF=0.46;MQM=60	BRCA1	missense,non_coding_exon	BRCA1:NM_007300.3:missense:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly,BRCA1:NM_007298.3:missense:MODERATE:exon14/22:c.1525A>G:p.Ser509Gly,BRCA1:NM_007297.3:missense:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly,BRCA1:NM_007299.3:missense:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly,BRCA1:NM_007294.3:missense:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon15/23:n.4973A>G:		rs1799966	0.3558	0.3490	7852/3646/290	0.3266	-0.1120	T	D,T,D,T,D,T,T,T,D,.,D,D,D	B,B,B,P,B,B,B,B	B,B,B,B,B,B,B,B	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000031194.5 [other]; RCV000048673.4 [likely benign]; RCV000130704.2 [likely benign]; RCV000167795.2 [likely benign]; RCV000034753.3 [benign]; RCV000048672.5 [benign]; RCV000112410.5 [benign]; RCV000119096.2 [benign]; RCV000120260.4 [benign]; RCV000128996.2 [benign]; 	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1]; 	COSM3755560, COSM3755559
chr17	41234470	41234470	A	G	het		QUAL=408;DP=32;AF=0.47;MQM=60	BRCA1	synonymous,non_coding_exon	BRCA1:NM_007300.3:synonymous:LOW:exon12/24:c.4308T>C:p.Ser1436Ser,BRCA1:NM_007298.3:synonymous:LOW:exon11/22:c.999T>C:p.Ser333Ser,BRCA1:NM_007297.3:synonymous:LOW:exon11/22:c.4167T>C:p.Ser1389Ser,BRCA1:NM_007299.3:synonymous:LOW:exon12/22:c.999T>C:p.Ser333Ser,BRCA1:NM_007294.3:synonymous:LOW:exon12/23:c.4308T>C:p.Ser1436Ser,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon12/23:n.4444T>C:		rs1060915	0.3363	0.3430	7653/3619/159	0.3260	-0.1190	T				113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000112313.5 [benign]; RCV000114988.2 [benign]; RCV000128938.2 [benign]; RCV000152866.4 [benign]; 		
chr17	41244000	41244000	T	C	het		QUAL=5701;DP=346;AF=0.49;MQM=60	BRCA1	missense,intron,non_coding_exon	BRCA1:NM_007300.3:missense:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg,BRCA1:NM_007297.3:missense:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg,BRCA1:NM_007294.3:missense:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.788-951A>G:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.788-951A>G:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.3684A>G:		rs16942	0.3526	0.3480	7768/3592/284	0.3244	-0.3650	T	T,T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000034742.3 [benign]; RCV000048229.4 [benign]; RCV000112115.5 [benign]; RCV000120278.4 [benign]; RCV000128991.2 [benign]; RCV000157734.1 [benign]; 	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1]; 	COSM3755561, COSM148277
chr17	41244435	41244435	T	C	het	pred_pathogenic	QUAL=13534;DP=951;AF=0.48;MQM=60	BRCA1	missense,intron,non_coding_exon	BRCA1:NM_007300.3:missense:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly,BRCA1:NM_007297.3:missense:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly,BRCA1:NM_007294.3:missense:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.788-1386A>G:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.788-1386A>G:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.3249A>G:		rs16941	0.3357	0.3430	7641/3610/156	0.3255	-0.4800	T	D,D,D,D,D,D,D	B,B,B,B,P,B	B,B,B,B,P,B	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000034738.3 [benign]; RCV000112006.5 [benign]; RCV000114987.2 [benign]; RCV000120276.5 [benign]; RCV000128978.2 [benign]; 	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1]; 	COSM3755563, COSM3755562
chr17	41244936	41244936	G	A	het	phylop_high	QUAL=2483;DP=128;AF=0.59;MQM=60	BRCA1	missense,intron,non_coding_exon	BRCA1:NM_007300.3:missense:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu,BRCA1:NM_007297.3:missense:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu,BRCA1:NM_007294.3:missense:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.787+1825C>T:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.787+1825C>T:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.2748C>T:		rs799917	0.5439	0.4100	11586/3799/3500	0.3359	4.2460	T	T,T,T,T,T,T,T	B,B,B,B,B,B	B,B,B,B,B,B	113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000034735.3 [benign]; RCV000111903.5 [benign]; RCV000114986.2 [benign]; RCV000120285.4 [benign]; RCV000132149.2 [benign]; RCV000077111.2 [likely benign]; RCV000221093.1 [uncertain significance]; RCV000047899.2 [not provided]; RCV000111902.1 [uncertain significance]; 	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1]; 	COSM148278, COSM3755564
chr17	41245237	41245237	A	G	het		QUAL=1908;DP=126;AF=0.46;MQM=60	BRCA1	synonymous,intron,non_coding_exon	BRCA1:NM_007300.3:synonymous:LOW:exon10/24:c.2311T>C:p.Leu771Leu,BRCA1:NM_007297.3:synonymous:LOW:exon9/22:c.2170T>C:p.Leu724Leu,BRCA1:NM_007294.3:synonymous:LOW:exon10/23:c.2311T>C:p.Leu771Leu,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.787+1524T>C:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.787+1524T>C:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.2447T>C:		rs16940	0.3353	0.3420	7603/3578/154	0.3237						113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000111822.5 [benign]; RCV000114985.2 [benign]; RCV000128982.2 [benign]; RCV000152867.3 [benign]; 		COSM3755566, COSM3755565
chr17	41245466	41245466	G	A	het		QUAL=627;DP=60;AF=0.43;MQM=60	BRCA1	synonymous,intron,non_coding_exon	BRCA1:NM_007300.3:synonymous:LOW:exon10/24:c.2082C>T:p.Ser694Ser,BRCA1:NM_007297.3:synonymous:LOW:exon9/22:c.1941C>T:p.Ser647Ser,BRCA1:NM_007294.3:synonymous:LOW:exon10/23:c.2082C>T:p.Ser694Ser,BRCA1:NM_007298.3:intron:MODIFIER:exon9/21:c.787+1295C>T:,BRCA1:NM_007299.3:intron:MODIFIER:exon10/21:c.787+1295C>T:,BRCA1:NR_027676.1:non_coding_exon:MODIFIER:exon10/23:n.2218C>T:		rs1799949	0.3365	0.3480	7796/3607/286	0.3244						113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1|Pancreatic cancer,susceptibility to,4];	RCV000111763.4 [benign]; RCV000114984.2 [benign]; RCV000128966.2 [benign]; RCV000152868.4 [benign]; 		COSM148280, COSM3755567
chr17	59760996	59760996	A	G	hom		QUAL=7602;DP=305;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:NM_032043.2:synonymous:LOW:exon20/20:c.3411T>C:p.Tyr1137Tyr		rs4986763	0.6208	0.5940	22043/11338/2201	0.5869						605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];	RCV000162378.1 [benign]; 		
chr17	59763347	59763347	A	G	hom	low_DP	QUAL=355;DP=11;AF=1.00;MQM=60	BRIP1	missense	BRIP1:NM_032043.2:missense:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro		rs4986764	0.6278	0.5970	22365/11454/2344	0.5890	0.1360	T	T	B	B	605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];	RCV000120400.1 [not provided]; RCV000132148.2 [benign]; 	CM046104 [CLASS=DP MUT=REF PHEN="Breast cancer association with" GENE=BRIP1]; 	
chr17	59763465	59763465	T	C	hom		QUAL=3657;DP=113;AF=1.00;MQM=60	BRIP1	synonymous	BRIP1:NM_032043.2:synonymous:LOW:exon19/20:c.2637A>G:p.Glu879Glu		rs4986765	0.8151	0.7190	32088/14734/4248	0.6555						605882 [BRIP1 (confirmed) Breast cancer,early-onset|Fanconi anemia,complementation group J];	RCV000162379.1 [benign]; 		COSM437064, COSM1479821
chr18	19995753	19995753	T	C	hom	low_DP	QUAL=452;DP=17;AF=1.00;MQM=60	CTAGE1	synonymous	CTAGE1:NM_172241.2:synonymous:LOW:exon1/1:c.2022A>G:p.Pro674Pro		rs9946145	0.6855	0.8430	44643/28030/667	0.9089									
chr18	19996011	19996011	G	A	het		QUAL=1909;DP=133;AF=0.46;MQM=60	CTAGE1	synonymous	CTAGE1:NM_172241.2:synonymous:LOW:exon1/1:c.1764C>T:p.Leu588Leu		rs61747184	0.4942	0.4990	15457/8071/1094	0.4606									
chr19	17389648	17389648	C	T	het		QUAL=1536;DP=105;AF=0.48;MQM=60	BABAM1	splice_region&intron	BABAM1:NM_001033549.2:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288756.1:splice_region&intron:LOW:exon8/8:c.787-6C>T:,BABAM1:NM_001288757.1:splice_region&intron:LOW:exon5/5:c.562-6C>T:,BABAM1:NM_014173.3:splice_region&intron:LOW:exon8/8:c.787-6C>T:		rs10406920	0.1118	0.1480	1404/941/140	0.1799									
chr19	17389704	17389704	G	A	het		QUAL=7788;DP=525;AF=0.47;MQM=60	BABAM1	synonymous	BABAM1:NM_001033549.2:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288756.1:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys,BABAM1:NM_001288757.1:synonymous:LOW:exon6/6:c.612G>A:p.Lys204Lys,BABAM1:NM_014173.3:synonymous:LOW:exon9/9:c.837G>A:p.Lys279Lys		rs8170	0.1124	0.1520	1581/1048/168	0.1811								CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1]; 	COSM438891, COSM438892
chr20	14167283	14167283	A	G	hom		QUAL=893;DP=30;AF=1.00;MQM=60	MACROD2	intron	MACROD2:NM_080676.5:intron:MODIFIER:exon3/16:c.271+100909A>G:	L1PA16	rs6074704	0.4792	0.0000	0/0/0	0.0000									
chr20	48301146	48301146	G	A	hom		QUAL=39462;DP=1193;AF=1.00;MQM=60	B4GALT5	intron	B4GALT5:NM_004776.3:intron:MODIFIER:exon1/8:c.116-27907C>T:		rs6512586	0.4681	0.5160	15518/8865/587	0.5455									
chrX	52825546	52825546	C	G	hom		QUAL=2695;DP=90;AF=1.00;MQM=60	SPANXN5	synonymous	SPANXN5:NM_001009616.3:synonymous:LOW:exon2/2:c.201G>C:p.Leu67Leu		rs2806838	0.9793	0.9750	25783/13739/3153	0.9704									
chr9	32973710	32973710	A	-	het		QUAL=12962;DP=808;AF=0.49;MQM=59	APTX	intron	APTX:NM_001195248.1:intron:MODIFIER:exon7/7:c.917-60delT:,APTX:NM_001195249.1:intron:MODIFIER:exon7/7:c.875-60delT:,APTX:NR_036579.1:intron:MODIFIER:exon7/7:n.1118-60delT:,APTX:NM_001195254.1:intron:MODIFIER:exon6/6:c.713-60delT:,APTX:NR_036578.1:intron:MODIFIER:exon7/7:n.971-60delT:,APTX:NM_001195250.1:intron:MODIFIER:exon6/6:c.755-60delT:,APTX:NM_001195251.1:intron:MODIFIER:exon8/8:c.875-24delT:,APTX:NM_001195252.1:intron:MODIFIER:exon7/7:c.701-60delT:,APTX:NM_175069.2:intron:MODIFIER:exon7/7:c.917-24delT:,APTX:NM_175073.2:intron:MODIFIER:exon8/8:c.875-60delT:,APTX:NR_036576.1:intron:MODIFIER:exon7/7:n.949-60delT:,APTX:NR_036577.1:intron:MODIFIER:exon7/7:n.839-60delT:	(A)n,(A)n	rs538244166	0.4667	0.1970	31/24/0	0.0000						606350 [APTX (confirmed) Ataxia,early-onset,with oculomotor apraxia and hypoalbuminemia],606350 [APTX (confirmed) Ataxia,early-onset,with oculomotor apraxia and hypoalbuminemia];			
